久久久久久网,国产视频97

Dihydroartemisinin;
3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol,decahydro-3,6,9-trimethyl-, [3R-(3a,5ab,6b,8ab,9a,10a,12b,12aR*)]-;
Alaxin;
Cotecxin;
Dihydroartemisinin;
Dihydroartemisinine;
Dihydroqinghaosu;
Dynamax;
Salaxin;
Santecxin;
b-Dihydroartemisinin;

C15H24O5

詳情

供應(yīng)商

119520-06-8

鹽酸齊帕特羅;
齊帕特羅鹽酸鹽;
(+/1)-反式-4,5,6,7-四氫-7-羥基-6-(異丙基氨基)咪唑并[4,5,1-jk]-[1]苯并氮?

Zilpaterol HCl;
Imidazo[4,5,1-jk][1]benzazepin-2(1H)-one,4,5,6,7-tetrahydro-7-hydroxy-6-[(1-methylethyl)amino]-, monohydrochloride,(6R,7R)-rel- (9CI);
Imidazo[4,5,1-jk][1]benzazepin-2(1H)-one,4,5,6,7-tetrahydro-7-hydroxy-6-[(1-methylethyl)amino]-, monohydrochloride,trans-

圣約翰麥芽汗貫葉金絲桃提取物

St.-john's-wort, Hypericum perforatum, ext.;
St.-john's-wort,Hypericum perforatum,ext.

無

詳情

供應(yīng)商

137647-92-8

Axinastatin 1 (9CI);
1H-Dipyrrolo[1,2-a:1',2'-j][1,4,7,10,13,16,19]heptaazacycloheneicosine,cyclic peptide deriv.;
Cyclo(L-asparaginyl-L-prolyl-L-phenylalanyl-L-valyl-L-valyl-L-prolyl-L-valyl);
Malaysiatin;
Pseudoaxinellin

Axinastatin 4 (9CI);
1H-Dipyrrolo[1,2-a:1',2'-j][1,4,7,10,13,16,19]heptaazacycloheneicosine,cyclic peptide deriv.;
Cyclo(L-leucyl-L-threonyl-L-prolyl-L-leucyl-L-tryptophyl-L-valyl-L-prolyl)

Acenaphtho[1,2-j]fluoranthene(6CI,7CI,8CI,9CI);
Benzo[1,2-a:3,4-a']diacenaphthylene

Benz[a]oxireno[3,4]benz[1,2-j]acridine-2,3-diol,1a,2,3,13c-tetrahydro-, (1aR,2R,3S,13cS)-rel-;
Benz[a]oxireno[3,4]benz[1,2-j]acridine-2,3-diol,1a,2,3,13c-tetrahydro-, (1aa,2b,3a,13ca)-

Benzo[d]-1,3-dioxolo[4,5-g]pyrido[4,3,2-jk][2]benzazepin-11-ol,5,6,7,7a-tetrahydro-7-methyl- (9CI);
Spiguetidine

Benzamide,4-[(4-azido-3-iodophenyl)azo]-N-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]-(9CI);
Denny-jaffe reagent

Benzo[d]-1,3-dioxolo[4,5-g]pyrido[4,3,2-jk][2]benzazepine,5,6,7,7a-tetrahydro-7-methyl- (9CI);
Dragabine

Benz[a]oxireno[3,4]benz[1,2-j]acridine-2,3-diol,1a,2,3,13c-tetrahydro-, (1aR,2S,3R,13cS)-rel-;
Benz[a]oxireno[3,4]benz[1,2-j]acridine-2,3-diol,1a,2,3,13c-tetrahydro-, (1aa,2a,3b,13ca)- (9CI)

Benzo[lmn]dibenzimidazo[2,1-b:1',2'-j][3,8]phenanthroline-6,9-dione,3,12-diethoxy-;
Bisbenzimidazo[2,1-b:1',2'-j]benzo[lmn][3,8]phenanthroline-6,9-dione,3,12-diethoxy- (6CI,8CI,9CI)

Cyclo(L-a-glutamyl-L-leucyl-L-tryptophyl-L-prolyl-L-phenylalanylglycyl-L-prolyl),stereoisomer;
1H-Dipyrrolo[1,2-a:1',2'-j][1,4,7,10,13,16,19]heptaazacycloheneicosine,cyclic peptide deriv.;
Hymenamide C

Cyclo(L-phenylalanyl-L-phenylalanyl-L-prolyl-L-threonyl-L-threonyl-L-prolyl-L-tyrosyl);
1H-Dipyrrolo[1,2-a:1',2'-j][1,4,7,10,13,16,19]heptaazacycloheneicosine,cyclic peptide deriv.;
Hymenamide E

Cyclo(L-alanyl-L-isoleucyl-L-prolyl-L-tyrosyl-L-a-aspartyl-L-prolyl-L-leucyl)(9CI);
1H-Dipyrrolo[1,2-a:1',2'-j][1,4,7,10,13,16,19]heptaazacycloheneicosine,cyclic peptide deriv.;
Hymenamide D

Cyclopentaneaceticacid, 3-oxo-2-(2-pentenyl-2,3-d2)-, methyl ester, [1a,2b(Z)]- (9CI);
(+/-)-jASMONIC ACID-9,10-D2 METHYL ESTER;
METHYL (+/-)-jASMONATE-9,10-D2;
(+/-)-jasmonic acid-9,10-d2 methyl ester, ca. 97atom%d;
methyl (+/-)-jasmonate-9,10-d2, ca. 97atom%d;
Methyl (+/-)-jasmonate-9,10-d2 ca. 97atom%D (containing ca. 5% of Methyl (+/-)-7-epi-jasmonate-9,10-d2) (200micro g/ml in Acetonitrile) [Internal standard for qualitative analysis of endogenous Methyl Jasmonate]

Cyclopentaneaceticacid, 3-oxo-2-(2-pentenyl-2,3-d2)-, [1a,2b(Z)]- (9CI);
(+/-)-jASMONIC ACID-9,10-D2;
(+/-)-jasmonic acid-9,10-d2, ca. 96atom%d;
(+/-)-jasmonic Acid-9,10-d2 ca. 96atom%D (containing ca. 5% of (+/-)-7-epi-jasmonic Acid-9,10-d2) (200micro g/ml in Acetonitrile) [Internal standard for qualitative analysis of endogenous Jasmonic Acid]

Cyclopent[ef]imidazo[4,5,1-jk][1,4]benzodiazepine(9CI);
Cyclopent[ef]imidazo[4,5,1-jk][1,4]benzodiazepine (9CI)

C12H7N3

詳情

供應(yīng)商

化工產(chǎn)品